APVOVSGOSS• 6 Months (Normalized)
APVO vs GOSS (Aptevo Therapeutics Inc. vs Gossamer Bio Inc.)
Showing Closing Date Range from Mar, 18 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
APVO Performance $1.8
-61.46%
Aptevo Therapeutics Inc.
Normalized Baseline0.00%
GOSS Performance $10.7
+2365.44%
Gossamer Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
-2426.9%
GOSS outperforming by 2426.90%
APVOGOSS
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
APVO GOSS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | APVO Price | APVO Gain (%) | GOSS Price | GOSS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $1.80 | -61.46% | $10.70 | +2365.44% | -2426.90% |
| Sep 11, 2026 | $1.82 | -61.03% | $10.73 | +2372.35% | -2433.38% |
| Sep 10, 2026 | $1.83 | -60.81% | $11.36 | +2517.51% | -2578.32% |
| Sep 09, 2026 | $1.85 | -60.49% | $12.80 | +2849.31% | -2909.80% |
| Sep 08, 2026 | $1.88 | -59.74% | $14.40 | +3217.97% | -3277.71% |
| Sep 04, 2026 | $1.74 | -62.74% | $14.00 | +3125.81% | -3188.55% |
| Sep 03, 2026 | $1.71 | -63.38% | $14.05 | +3136.87% | -3200.25% |
| Sep 02, 2026 | $2.60 | -44.33% | $0.17 | -60.14% | +15.81% |
| Sep 01, 2026 | $2.34 | -49.89% | $0.17 | -61.52% | +11.63% |
| Aug 31, 2026 | $2.44 | -47.75% | $0.17 | -60.83% | +13.08% |
| Aug 28, 2026 | $2.37 | -49.36% | $0.17 | -60.83% | +11.47% |
| Aug 27, 2026 | $2.42 | -48.18% | $0.17 | -60.83% | +12.65% |
| Aug 26, 2026 | $2.41 | -48.39% | $0.17 | -59.91% | +11.52% |
| Aug 25, 2026 | $2.46 | -47.32% | $0.21 | -52.76% | +5.44% |
| Aug 24, 2026 | $2.41 | -48.39% | $0.18 | -59.68% | +11.29% |
Page 1 of 9